Gene Page:EPHA2
Summary?
基因 | 1969 |
象征 | EPHA2 |
Synonyms | ARCC2|CTPA|CTPP1|CTRCT6|ECK |
Description | EPH receptor A2 |
参考erence | MIM:176946|HGNC:HGNC:3386|ENSEMBL:ENSG00000142627|HPRD:01494|Vega:Otthumg00000009527 |
基因类型 | 蛋白质编码 |
Map location | 136 |
Pascal p-value | 0.22 |
TADA p-value | 0.004 |
胎儿β | 0.016 |
主持人 | Myers' cis & trans |
Support | CompositeSet |
Gene in Data Sources
基因集名称 | Method of gene set | Description | 信息 |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
DNM:Fromer_2014 | Whole Exome Sequencing analysis | 这项研究报道了WES对623个精神分裂症三重奏的研究,该研究使用基因组DNA报告了DNM。 | |
GO_Annotation | 将与神经相关的关键字映射到基因本体论注释 | 与神经相关的关键字的命中:1 |
Section I. Genetics and epigenetics annotation
DNM表
Gene | 染色体 | 位置 | 参考 | alt | 成绩单 | AA change | Mutation type | 筛 | CG46 | 特征 | 学习 |
---|---|---|---|---|---|---|---|---|---|---|---|
EPHA2 | CHR1 | 16458218..16458219 | CG | C | NM_004431 NM_004431 |
。 。 |
拼接 frameshift |
Schizophrenia | DNM:Fromer_2014 |
eQTL annotation
SNP ID | 染色体 | 位置 | 主持人 | Gene Entrez ID | pvalue | QVALUE | TSS距离 | EQTL类型 |
---|---|---|---|---|---|---|---|---|
RS2746486 | CHR1 | 17465173 | EPHA2 | 1969 | 0.19 | 顺式 |
第二节。转录组注释
一般基因表达(GTEX)
![Not available](http://www.tjghsg.com/bioinfo/SZGR/GeneImg/EPHA2_DE_GTEx.png)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
时间变化的基因表达(brainspan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1:胎儿(13-26个概念后周),ST2:婴儿早期至童年(4个月至11年)和ST3:青春期至成年期(13-23年)
所示的栏表示表达分布的较低25%和上层25%。
大脑区域的顶级共表达基因
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
PSMA7 | 0.93 | 0.95 |
PSMD13 | 0.91 | 0.92 |
ruvbl2 | 0.90 | 0.93 |
CCT7 | 0.90 | 0.90 |
EIF6 | 0.90 | 0.94 |
RRP9 | 0.89 | 0.90 |
DCTPP1 | 0.89 | 0.92 |
WIBG | 0.89 | 0.90 |
CFL1 | 0.89 | 0.90 |
C19orf10 | 0.89 | 0.92 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
AF347015.8 | -0.75 | -0.76 |
AF347015.33 | -0.75 | -0.77 |
AF347015.27 | -0.74 | -0.77 |
AF347015.15 | -0.74 | -0.77 |
mt-cyb | -0.74 | -0.76 |
MT-CO2 | -0.74 | -0.72 |
AF347015.2 | -0.73 | -0.75 |
AF347015.26 | -0.73 | -0.78 |
AF347015.31 | -0.72 | -0.72 |
AF347015.9 | -0.67 | -0.73 |
第三节。基因本体论注释
分子功能 | 去学期 | 证据 | 神经关键字 | PubMed ID |
---|---|---|---|---|
去:0000166 | nucleotide binding | IEA | - | |
GO:0004872 | receptor activity | IEA | - | |
去:0005003 | ephrin受体活性 | IEA | - | |
去:0005524 | ATP binding | IEA | - | |
GO:0016740 | 转移酶活性 | IEA | - | |
生物过程 | 去学期 | 证据 | 神经关键字 | PubMed ID |
GO:0030182 | 神经元分化 | IEA | 神经元(GO期限:8) | - |
去:0006468 | protein amino acid phosphorylation | IEA | - | |
GO:0007165 | 信号转导 | TAS | 2174105 | |
GO:0048013 | ephrin receptor signaling pathway | IEA | - | |
GO:0007275 | multicellular organismal development | TAS | 7918100 | |
Cellular component | 去学期 | 证据 | 神经关键字 | PubMed ID |
去:0016020 | membrane | IEA | - | |
GO:0016021 | 膜不可或缺 | IEA | - | |
去:0005887 | integral to plasma membrane | TAS | 2174105 |
Section IV. Protein-protein interaction annotation
互动者 | 别名b | 官方全名b | 实验 | Source | PubMed ID |
---|---|---|---|---|---|
ACP1 | haap |MGC111030 |MGC3499 | acid phosphatase 1, soluble | - | HPRD,BioGRID | 12167657 |
EFNA1 | B61 |ECKLG | EFL1 | EPLG1 | LERK1 | TNFAIP4 | ephrin-a1 | The membrane bound ligand B61 interacts with the receptor ECK. This interaction was modeled on a demonstrated interaction between B61 from human and ECK from mouse. | 绑定 | 7973638|8755474 |
EFNA1 | B61 |ECKLG | EFL1 | EPLG1 | LERK1 | TNFAIP4 | ephrin-a1 | - | HPRD | 7973638|8755474 |
EFNA2 | ELF-1 |eplg6 |hek7-l |LERK6 | ephrin-a2 | - | HPRD | 8755474 |
EFNA3 | efl2 |eplg3 |EHK1-L |lerk3 | ephrin-a3 | 膜结合的配体EHK1-L与受体ECK相互作用。这种相互作用是在人类和来自小鼠ECK的EHK1-L之间的相互作用上建模的。 | 绑定 | 7973638|8755474 |
EFNA3 | efl2 |eplg3 |EHK1-L |lerk3 | ephrin-a3 | - | HPRD | 12907451 |
EFNA4 | efl4 |eplg4 |lerk4 |MGC125826 | ephrin-a4 | - | HPRD | 10607706 |
EFNA4 | efl4 |eplg4 |lerk4 |MGC125826 | ephrin-a4 | - | HPRD | 8755474|10607706 |
EFNA5 | AF1 |efl5 |eplg7 |Glc1m |lerk7 |破布 | ephrin-a5 | - | HPRD | 9245480 |
GRB2 | 灰烬|EGFRBP-GRB2 |Grb3-3 |MST084 |MSTP084 | 生长因子受体结合蛋白2 | - | HPRD,BioGRID | 12400011 |
PIK3R1 | GRB1 | p85 | p85-ALPHA | 磷酸肌醇3-激酶,调节亚基1(alpha) | 亲和力捕获 - 韦斯特恩 重构的复合物 Two-hybrid |
Biogrid | 7982920 |
PTK2 | FADK | FAK | FAK1 | pp125FAK | PTK2 protein tyrosine kinase 2 | - | HPRD,BioGRID | 10655584 |
PTPN11 | bptp3 |CFC |MGC14433 |NS1 |PTP-1D |PTP2C |SH-PTP2 |sh-ptp3 |SHP2 | protein tyrosine phosphatase, non-receptor type 11 | 亲和力捕获 - 韦斯特恩 | Biogrid | 10655584 |
SHC1 | FLJ26504 | SHC | SHCA | SHC(SRC同源性2结构域)转化蛋白1 | - | HPRD,BioGRID | 12400011 |
SLA | Sla1 |拍击 | 类似于SRC的适应器 | - | HPRD,BioGRID | 7543898 |
TNFAIP1 | B12 |B61 |EDP1 |MGC2317 | 肿瘤坏死因子,α诱导的蛋白1(内皮) | - | HPRD | 7536959 |
Section V. Pathway annotation
第六节。microRNA注释
mirna家族 | Target position | miRNA ID | mirna seq | ||
---|---|---|---|---|---|
UTR开始 | UTR结束 | 匹配方法 | |||
miR-124/506 | 472 | 478 | M8 | hsa-miR-506 | UAAGGCACCCUUCUGAGUAGA |
HSA-MIR-124brain | UAAGGCACGCGGUGAAUGCC | ||||
miR-141/200a | 754 | 761 | 1A,M8 | HSA-MIR-141 | uaacacugucugugugugugaugg |
hsa-miR-200a | UAACACUGUCUGGUAACGAUGU | ||||
mir-224 | 833 | 839 | 1A | hsa-miR-224 | CAAGUCACUAGUGGUUCCGUUUA |
miR-26 | 36 | 43 | 1A,M8 | HSA-MIR-26Abrain | UUCAAGUAAUCCAGGAUAGGC |
HSA-MIR-26BSZ | UUCAAGUAAUUCAGGAUAGGUU | ||||
miR-93.hd/291-3p/294/295/302/372/373/520 | 223 | 230 | 1A,M8 | hsa-miR-93brain | aaagugcuguucgugcagguag |
hsa-miR-302a | uaagugcuugcauguuuguga | ||||
hsa-miR-302b | UAAGUGCUUCCAUGUUUUAGUAG | ||||
hsa-miR-302c | uaagugcuuccauguucagugg | ||||
hsa-miR-302d | UAAGUGCUUCCAUGUUUGAGUGU | ||||
HSA-MIR-372 | AAAGUGCUGCGACAUUUGAGCGU | ||||
HSA-MIR-373 | Gaagugcuucgauuuggggugu | ||||
HSA-MIR-520E | Aaagugcuuuuuugaggg | ||||
hsa-miR-520a | AAAGUGCUUCCCUUUGGACUGU | ||||
hsa-miR-520b | aaagugcuuuuuuagaggg | ||||
hsa-miR-520c | AAAGUGCUUCCUUUUAGAGGGUU | ||||
hsa-miR-520d | aaaguguuugugggguggguu |